File(s) under permanent embargo
Predictors of CD4 count change over 8 months of follow up in HIV-1-infected patients with a CD4 count ≥ 300 cells/μL who were assigned to 7.5 MIU interleukin-2
journal contribution
posted on 2007-03-01, 00:00 authored by Z Fox, F Antunes, R Davey, B Gazzard, N Klimas, A Labriola, M Losso, J D Neaton, A Phillips, K Ruxrungtham, S Staszewski, L Weiss, D J Lundgren, L Aguilar, E B Angel, S Aquilia, W Belloso, J Benetucci, V Bittar, P Cahn, A Casiro, J Contarelli, J Corral, L Daciuk, D David, I Ferrari, D Fridman, V Galache, G Guaragna, S Ivalo, H Laplume, I Lanusse, M B Lasala, R Lattes, J Lasovsky, G Lopardo, L Lourtau, S Lupo, A Maranzana, C Marson, L Massera, M D L Sanchez, C Somenzini, M Tocci, S Algar, J Anderson, D Baker, K Blavius, M Bloch, M Boyle, D Bradford, P Britton, L Carrall, A Carr, J Chuah, M Curry, C D'Arcy-Evans, P Dobson, N Doong, C Egan, W Ferguson, R Finlayson, M French, A Frater, J Gold, P Habel, K Haig, R Holland, N Hyland, J Hoy, J Hudson, R James, J Leung, K Lowe, K MacRae, M McMurchie, N Medland, S Miller, J Murray, R Newman, O David, J Patching, R Primrose, H Ree, R Richardson, Gary RogersGary Rogers, J Roney, N Roth, J Sarangapany, D Shaw, C Silberberg, A Skett, R Vale, C Villella, A Walker, A Watson, N Wendt, H WoodPredictors of CD4 count change over 8 months of follow up in HIV-1-infected patients with a CD4 count ≥ 300 cells/μL who were assigned to 7.5 MIU interleukin-2
History
Journal
HIV MedicineVolume
8Issue
2Pagination
112 - 123Publisher
BLACKWELL PUBLISHINGLocation
EnglandPublisher DOI
ISSN
1464-2662eISSN
1468-1293Language
EnglishPublication classification
C1.1 Refereed article in a scholarly journalUsage metrics
Categories
No categories selectedKeywords
Science & TechnologyLife Sciences & BiomedicineInfectious Diseases7.5 MIU proleukinCD4 cell count responsessubcutaneous recombinant interleukin-2HUMAN-IMMUNODEFICIENCY-VIRUSRANDOMIZED CONTROLLED-TRIALDOSE SUBCUTANEOUS INTERLEUKIN-2POTENT ANTIRETROVIRAL THERAPYHIV-1 INFECTIONINTRAVENOUS INTERLEUKIN-2EFFICACYREGRESSIONVANGUARDTYPE-1IMMUNODEFICIENCY-VIRUS TYPE-1ANTIRETROVIRAL THERAPYCONTROLLED-TRIALESPRIT Research Group
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC